Literature DB >> 25141273

Risk of bias in trial-based economic evaluations: identification of sources and bias-reducing strategies.

Silvia M A A Evers1, Mickaël Hiligsmann, Charles Christian Adarkwah.   

Abstract

OBJECTIVE: The objectives of this article are first to give an overview of the risks of bias in trial-based economic evaluations and, second, to identify how key sources for bias can be revealed and overcome (i.e. what bias-reducing strategies might be employed) in future trial-based economic evaluations in the field of health psychology.
DESIGN: Narrative review discussing sources of bias in trial-based economic evaluations and bias-reducing strategies.
RESULTS: We identified 11 biases and assigned them to a particular trial phase. A distinction is made between pre-trial biases, biases during the trial and biases that are relevant after the actual trial. All potential forms of bias are discussed in detail and strategies are shown to detect and overcome these biases.
CONCLUSION: In order to avoid bias in trial-based economic evaluations, one has to be aware of all the possible forms of bias. All stakeholders have to examine trial-based economic evaluations in a rigorous and stringent manner. This article can be helpful in this examination as it gives an overview of the possible biases which researchers should take into account.

Keywords:  bias; bias-reducing strategies; cost and outcomes; economic evaluation; systematic error

Mesh:

Year:  2014        PMID: 25141273     DOI: 10.1080/08870446.2014.953532

Source DB:  PubMed          Journal:  Psychol Health        ISSN: 0887-0446


  13 in total

1.  Breast cancer-related lymphedema and its treatment: how big is the financial impact?

Authors:  Tessa De Vrieze; Nick Gebruers; Ines Nevelsteen; Wiebren A A Tjalma; Sarah Thomis; An De Groef; Lore Dams; Vincent Haenen; Nele Devoogdt
Journal:  Support Care Cancer       Date:  2020-11-24       Impact factor: 3.603

Review 2.  A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?

Authors:  Wendy L St. Peter; Lori D Wazny; Eric Weinhandl; Katie E Cardone; Joanna Q Hudson
Journal:  Drugs       Date:  2017-07       Impact factor: 9.546

Review 3.  "Cost-effectiveness of ACL treatment is dependent on age and activity level: a systematic review".

Authors:  R Deviandri; H C van der Veen; A M T Lubis; I van den Akker-Scheek; M J Postma
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-08-23       Impact factor: 4.114

4.  The Cost-Effectiveness of Adjunctive Lifestyle Interventions for the Management of Cancer: A Systematic Review.

Authors:  Andrew Gallagher; Violetta Shersher; Duncan Mortimer; Helen Truby; Terry Haines
Journal:  Appl Health Econ Health Policy       Date:  2022-09-27       Impact factor: 3.686

Review 5.  How standard is standard care? Exploring control group outcomes in behaviour change interventions for young people with type 1 diabetes.

Authors:  K Ayling; S Brierley; B Johnson; S Heller; C Eiser
Journal:  Psychol Health       Date:  2014-10-20

6.  A Web-Based Computer-Tailored Alcohol Prevention Program for Adolescents: Cost-Effectiveness and Intersectoral Costs and Benefits.

Authors:  Ruben M W A Drost; Aggie T G Paulus; Astrid F Jander; Liesbeth Mercken; Hein de Vries; Dirk Ruwaard; Silvia M A A Evers
Journal:  J Med Internet Res       Date:  2016-04-21       Impact factor: 5.428

7.  Cost-effectiveness of phosphate binders among patients with chronic kidney disease not yet on dialysis: a long way to go.

Authors:  Rana Rizk
Journal:  BMC Nephrol       Date:  2016-07-08       Impact factor: 2.388

Review 8.  Health-Related Resource-Use Measurement Instruments for Intersectoral Costs and Benefits in the Education and Criminal Justice Sectors.

Authors:  Susanne Mayer; Aggie T G Paulus; Agata Łaszewska; Judit Simon; Ruben M W A Drost; Dirk Ruwaard; Silvia M A A Evers
Journal:  Pharmacoeconomics       Date:  2017-09       Impact factor: 4.981

Review 9.  Cost effectiveness of guided Internet-based interventions for depression in comparison with control conditions: An individual-participant data meta-analysis.

Authors:  Spyros Kolovos; Johanna M van Dongen; Heleen Riper; Claudia Buntrock; Pim Cuijpers; David D Ebert; Anna S Geraedts; Robin M Kenter; Stephanie Nobis; Andrea Smith; Lisanne Warmerdam; Jill A Hayden; Maurits W van Tulder; Judith E Bosmans
Journal:  Depress Anxiety       Date:  2018-01-12       Impact factor: 6.505

10.  Prevention of Surgical Site Infections: A Systematic Review of Cost Analyses in the Use of Prophylactic Antibiotics.

Authors:  Abdul K R Purba; Didik Setiawan; Erik Bathoorn; Maarten J Postma; Jan-Willem H Dik; Alex W Friedrich
Journal:  Front Pharmacol       Date:  2018-07-18       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.